Compare GKOS & SM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GKOS | SM |
|---|---|---|
| Founded | 1998 | 1908 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 9.1B |
| IPO Year | 2015 | 1996 |
| Metric | GKOS | SM |
|---|---|---|
| Price | $180.54 | $39.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 18 |
| Target Price | ★ $199.31 | $46.22 |
| AVG Volume (30 Days) | 979.8K | ★ 2.3M |
| Earning Date | 10-28-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 2.22% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.34 |
| Revenue | $507,442,000.00 | ★ $3,154,000,000.00 |
| Revenue This Year | $36.30 | $159.53 |
| Revenue Next Year | $23.25 | $0.34 |
| P/E Ratio | ★ N/A | $11.82 |
| Revenue Growth | ★ 32.33 | 17.24 |
| 52 Week Low | $80.91 | $17.45 |
| 52 Week High | $191.62 | $41.56 |
| Indicator | GKOS | SM |
|---|---|---|
| Relative Strength Index (RSI) | 65.62 | 60.20 |
| Support Level | $175.04 | $27.39 |
| Resistance Level | $184.68 | $41.56 |
| Average True Range (ATR) | 6.45 | 1.24 |
| MACD | 1.90 | 0.16 |
| Stochastic Oscillator | 80.18 | 73.07 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. The Company operates in the oil and gas extraction industry, focused on exploration and production activities, onshore in the United States. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.